← Back to headlines
Harmony Biosciences Reports Mixed Q4 Results
Harmony Biosciences Holdings, Inc. announced its Non-GAAP EPS of $0.57, missing estimates by $0.50, while its revenue of $243.78 million beat expectations by $3.46 million.
24 Feb, 12:33 — 24 Feb, 12:33
ℹOnly 1 source covers this story
